About
Psychedelics
Areas of Focus
Categories
PsychedelicNJ, NY, PA
Team (3)
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
4
As Collaborator
0
Total Enrollment
329
By Phase
PHASE2: 2PHASE1: 1PHASE1/PHASE2: 1
By Status
COMPLETED: 2ACTIVE_NOT_RECRUITING: 1ENROLLING_BY_INVITATION: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06215261Lead Sponsor
An Evaluation of the Safety and Efficacy of Methylone for the Treatment of PTSD
PHASE2Active, not recruiting
60 participants
Started: Apr 4, 2024 · Completed: Dec 31, 2025
NCT06303648Lead Sponsor
A Single, Ascending Dose Evaluation of the Safety, Pharmacokinetics of Methylone in Healthy Subjects
PHASE1Completed
40 participants
Started: Mar 20, 2024 · Completed: Jul 13, 2025
NCT06237426Lead Sponsor
An Evaluation of the Long-term Efficacy and Safety of Methylone for the Treatment of PTSD
PHASE2Enrolling by invitation
150 participants
Started: Mar 6, 2024 · Completed: May 31, 2027
NCT05741710Lead Sponsor
A Study to Assess the Use of Methylone in the Treatment of PTSD
PHASE1/PHASE2Completed
79 participants
Started: Mar 1, 2023 · Completed: Feb 19, 2025
Locations (1)
Headquarters
New York, NY, United States
Map
Loading map...